These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 197699)

  • 1. Epstein-Barr virus: transformation of lymphocytes separated by size or exposed to bromodeoxyuridine and light.
    Henderson E; Robinson J; Frank A; Miller G
    Virology; 1977 Oct; 82(1):196-205. PubMed ID: 197699
    [No Abstract]   [Full Text] [Related]  

  • 2. Surface markers and size of lymphocytes in human umbilical cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr Virus.
    Robinson J; Frank A; Henderson E; Schweitzer J; Miller G
    Infect Immun; 1979 Oct; 26(1):225-31. PubMed ID: 227794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Epstein-Barr virus after activation of the viral genome in a "virus-negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine (thymidine kinase-virus antigen-immunofluorescence-herpesvirus fingerprints).
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):78-82. PubMed ID: 4550511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of transformation of lymphocytes by Epstein-Barr virus.
    Henderson E; Miller G; Robinson J; Heston L
    Virology; 1977 Jan; 76(1):152-63. PubMed ID: 189490
    [No Abstract]   [Full Text] [Related]  

  • 5. Transformation of lymphocytes by Epstein-Barr virus requires only one-fourth of the viral genome.
    Mark W; Sugden B
    Virology; 1982 Oct; 122(2):431-43. PubMed ID: 6293180
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral and cellular DNA synthesis in nuclei from human lymphocytes transformed by Epstein-Barr virus.
    Benz WC; Strominger JL
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2413-7. PubMed ID: 166387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome.
    Klein G; Dombos L
    Int J Cancer; 1973 Mar; 11(2):327-37. PubMed ID: 4364259
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of hydrocortisone and bromodeoxyuridine (BUdR) on the Epstein-Barr herpes virus in human lymphoblastoid cell lines.
    Joncas JH; Leyritz M
    Rev Can Biol; 1974 Jun; 33(2):135-47. PubMed ID: 4369295
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure, metabolism, and functions of peripheral blood lymphocytes during long-term persistence of Epstein-Barr virus.
    Novitskii VV; Naslednikova IO; Urazova OI
    Bull Exp Biol Med; 2003 Oct; 136(4):344-7. PubMed ID: 14714078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus.
    Thorley-Lawson DA; Strominger JL
    Virology; 1978 May; 86(2):423-31. PubMed ID: 208257
    [No Abstract]   [Full Text] [Related]  

  • 11. Infection of human B lymphocytes with high multiplicities of Epstein-Barr virus: kinetics of EBNA expression, cellular DNA synthesis, and mitosis.
    Robinson J; Smith D
    Virology; 1981 Mar; 109(2):336-43. PubMed ID: 6259815
    [No Abstract]   [Full Text] [Related]  

  • 12. Epstein-Barr virus: stimulation by 5'-iododeoxyuridine or 5'-bromodeoxyuridine in human lymphoblastoid cells from a rhabdomyosarcoma.
    Houts GE; Szakacs MR; Szakacs JE
    Ann Clin Lab Sci; 1973; 3(6):429-33. PubMed ID: 4356930
    [No Abstract]   [Full Text] [Related]  

  • 13. Marked enhancement of interferon production in 5-bromodeoxyuridine treated human lymphoblastoid cells.
    Tovey MG; Begon-Lours J; Gresser I; Morris AG
    Nature; 1977 Jun; 267(5610):455-7. PubMed ID: 195215
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.
    Hampar B; Derge JG; Martos LM; Walker JL
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3185-9. PubMed ID: 4332012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).
    Gerber P
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):83-5. PubMed ID: 4550512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro.
    Rosén A; Gergely P; Jondal M; Klein G; Britton S
    Nature; 1977 May; 267(5606):52-4. PubMed ID: 193041
    [No Abstract]   [Full Text] [Related]  

  • 17. Bromodeoxyuridine and light treatment enhances responsiveness of pokeweed mitogen-stimulated human lymphocytes to autologous and allogeneic determinants.
    Puck JM; Abramson SL; Rich RR
    Cell Immunol; 1982 Sep; 72(1):102-12. PubMed ID: 6184170
    [No Abstract]   [Full Text] [Related]  

  • 18. Copy number and location of Epstein-Barr Viral genomes in neonatal human lymphocytes transformed after separation by size and treatment with mitogens.
    Anvret M; Miller G
    Virology; 1981 May; 111(1):47-55. PubMed ID: 6263010
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced representation of HL-A antigens on human lymphocytes after mitogenesis induced by phytohemagglutinin or Epstein-Barr virus.
    McCune JM; Humphreys RE; Yocum RR; Strominger JL
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3206-9. PubMed ID: 171657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of nuclear antigen (EBNA) synthesis without transformation in human cord lymphocytes by P3HR-1 strain of Epstein-Barr virus.
    Yamamoto N; Hinuma Y
    Virology; 1978 Sep; 89(2):623-6. PubMed ID: 213884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.